Skip to main content

MoneyWorks4Me

Nectar Lifesciences informs about disclosure

13 Dec 2024 Evaluate
Nectar Lifesciences has informed that it enclosed disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Isengard Direct PE LLC.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1768.00
Dr. Reddys Labs. 1340.25
Cipla 1382.00
Lupin 1996.55
Zydus Lifesciences 1239.95
View more..